AI is about to change healthcare. These 26 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
For someone considering Robert Half today, the big picture rests on whether you believe the business can translate its long track record and seasoned leadership into healthier profitability after a tough stretch. The latest Q4 2025 result, with net income and EPS down sharply year on year, reinforces that near term sentiment hinges on earnings pressure rather than growth excitement. Short term catalysts like any improvement in margins, stabilization in demand, or continued capital returns through dividends and buybacks now sit against weaker profit coverage and a dividend that is not well supported by current earnings. The market’s mixed price performance and the recent post‑earnings pullback suggest this latest report is material for how investors frame risk: softer profits, low current return on equity, but a share price that many still see as undervalued.
However, one key risk is that today’s thin margins persist longer than investors expect. Despite retreating, Robert Half's shares might still be trading 47% above their fair value. Discover the potential downside here.Explore 6 other fair value estimates on Robert Half - why the stock might be a potential multi-bagger!
Disagree with this assessment? Create your own narrative in under 3 minutes - extraordinary investment returns rarely come from following the herd.
Opportunities like this don't last. These are today's most promising picks. Check them out now:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com